Haleon PLC (HLN)
9.775
+0.02
(+0.15%)
USD |
NYSE |
Nov 05, 16:00
9.775
0.00 (0.00%)
After-Hours: 17:35
Haleon Price: 9.775 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 9.85 | 9.86 | 9.74 | 9.76 | 4.533M |
| Nov 01, 2024 | 9.80 | 9.818 | 9.71 | 9.73 | 4.814M |
| Oct 31, 2024 | 9.66 | 9.76 | 9.585 | 9.69 | 7.689M |
| Oct 30, 2024 | 9.77 | 9.86 | 9.75 | 9.80 | 6.371M |
| Oct 29, 2024 | 9.91 | 9.95 | 9.89 | 9.90 | 5.984M |
| Oct 28, 2024 | 9.97 | 10.00 | 9.93 | 9.98 | 5.228M |
| Oct 25, 2024 | 9.93 | 9.93 | 9.84 | 9.85 | 3.052M |
| Oct 24, 2024 | 9.94 | 9.95 | 9.865 | 9.89 | 4.175M |
| Oct 23, 2024 | 9.88 | 9.91 | 9.85 | 9.90 | 3.581M |
| Oct 22, 2024 | 9.88 | 9.93 | 9.860 | 9.91 | 3.572M |
| Oct 21, 2024 | 10.02 | 10.05 | 9.94 | 9.98 | 3.094M |
| Oct 18, 2024 | 10.06 | 10.09 | 10.02 | 10.09 | 1.982M |
| Oct 17, 2024 | 10.04 | 10.15 | 10.04 | 10.08 | 4.462M |
| Oct 16, 2024 | 10.09 | 10.14 | 10.06 | 10.13 | 4.209M |
| Oct 15, 2024 | 10.13 | 10.18 | 10.01 | 10.02 | 13.74M |
| Oct 14, 2024 | 10.10 | 10.15 | 10.06 | 10.10 | 18.06M |
| Oct 11, 2024 | 10.11 | 10.14 | 10.05 | 10.05 | 3.079M |
| Oct 10, 2024 | 10.14 | 10.16 | 10.09 | 10.12 | 4.341M |
| Oct 09, 2024 | 10.08 | 10.21 | 10.04 | 10.07 | 6.714M |
| Oct 08, 2024 | 10.08 | 10.14 | 10.04 | 10.14 | 6.876M |
| Oct 07, 2024 | 9.99 | 10.06 | 9.94 | 10.03 | 15.19M |
| Oct 04, 2024 | 10.20 | 10.37 | 10.18 | 10.37 | 5.058M |
| Oct 03, 2024 | 10.38 | 10.42 | 10.30 | 10.40 | 5.558M |
| Oct 02, 2024 | 10.56 | 10.58 | 10.49 | 10.54 | 7.872M |
| Oct 01, 2024 | 10.65 | 10.74 | 10.59 | 10.69 | 18.44M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.63
Minimum
Sep 02 2022
10.69
Maximum
Oct 01 2024
8.196
Average
8.26
Median
May 26 2023
Price Benchmarks
| Pfizer Inc | 27.98 |
| GSK PLC | 37.02 |
| Smith & Nephew PLC | 25.59 |
| Adaptimmune Therapeutics PLC | 0.829 |
| Biodexa Pharmaceuticals PLC | 5.65 |
Price Related Metrics
| PE Ratio | 28.89 |
| PS Ratio | 3.152 |
| PEG Ratio | 17.24 |
| Price to Book Value | 2.105 |
| Earnings Yield | 3.46% |
| Market Cap | 44.20B |
| PEGY Ratio | 8.775 |
| Operating PE Ratio | 16.58 |
| Normalized PE Ratio | 29.00 |